The Official Website of Drug Information Centre (Chhattisgarh State Pharmacy Council)
Corona - Awareness & Guidelines by C.G. Health Department.
Guidelines on Clinical Management of Severe Acute Respiratory Illness (SARI) in Suspect/Confirmed Novel Coronavirus (nCoV) Cases.
Prohibition of 328 Fixed Dose combination by the central government vide gazette notification nos S.O. 4379(E) dated 07/09/2018.
Approved Rational Fix Dose Combination by CDSCO in India.
Prohibition of Manufacture of Oxytocin With Conditions Under Section 26(A) With Effect From July 2018.
Swine Flu & Its Symptoms , Precautions & Treatments.
(Phone Help Line No 104 from CG State Govt ,for Any Assistance)
New Edition of National Formulary of India published after 31 years

After a long gap of 31 years, the fourth edition of the National Formulary of India (NFI), the guide for doctors, nurses, pharmacists and medical students, on basic drug information is available now.

Circular issued by CDSCO - http://www.cdsco.nic.in/circulars.htm

Prohibition of manufacturing sale & distribution of Gatifloxacin & Tegaserod formulation under the Gazette notification GSR 218(E) dated 16-03-2011

Drugs Prohibited vide Gazette notification, Feb 10, 2011 (G.S.R.82 (E))

Prohibition to Manufacture for sale & distribution and sale of Rosiglitazone & its formulation under the Gazette notification GSR910(E) dated 12-11-2010


Article : -
:: Drug & Cosmetics (AMENDMENT) Act 2008
:: 4th Edition of National Formulary of India (NFI)

:: Drugs During Pregnancy

:: Breastfeeding and Maternal Medication